Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization

World Journal of Gastroenterology

Volumn 10, Issue 2, 2004, Pages 190-194

  Xiao, En Hua ^a   Li, Jing Qing ^b   Huang, Jie Fu ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; CYCLINE; GELATIN SPONGE; IODINATED POPPYSEED OIL; KI 67 ANTIGEN; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TRANSFERASE;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CARCINOMA CELL; CELL DIVISION; CELL PROLIFERATION; CHEMOEMBOLIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER SURGERY; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; METABOLISM; NICK END LABELING; PATHOLOGY; PHYSIOLOGY; PREOPERATIVE CARE; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

EID: 1042304323     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i2.190     Document Type: Article

References (33)

1. Parks RW, Garden OJ. Liver resection for cancer. World J Gastroenterol 2001; 7: 766-771
2. Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001; 7: 445-454
3. Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I, Nakajo M. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: Evaluation of three kinds of kinds of regimens and analysis of prognostic factors. Cancer 2000; 88: 1574-1581
4. Xie X, Clausen OP, De Angelis P, Boysen M. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer 1999; 86: 913-920
5. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619
6. Xu HY, Yang YL, Guan XL, Song G, Jiang AM, Shi LJ. Expression of regulating gene and apoptosis index in primary liver cancer. World J Gastroenterol 2000; 6: 721-724
7. Perry A, Jenkins RB, O'Fallon JR, Schaefer PL, Kimmel DM, Mahoney MR, Scheithauer BW, Smith SM, Hill EM, Sebo TJ, Levitt R, Krook J, Tschetter LK, Morton RF, Buckner JC. Clinicopathologic study of 85 similarity treated patients with anaplastic astrocytic tumors: An analysis of DNA content (ploidy), cellular proliferation, and p53 expression. Cancer 1999; 86: 672-683
8. Kanazawa Y, Onda M, Tanaka N, Seya. Proliferation cell nuclear antigen and p53 protein expression in submucosal invasive colorectal carcinoma. J Nippon Medical School 2000; 67: 242-249
9. Elpek GO, Gelen T, Aksoy NH, Karpuzoglu T, Keles N. Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma. Pathol Oncol Res 2000; 6: 59-64
10. Zhang Z, Yuan Y, Gao H, Dong M, Wang L, Gong YH. Apoptosis, proliferation and p53 gene expression of H pylori associated gastric epithelial lesions. World J Gastroenterol 2001; 7: 779-782
11. Fukuse T, Hirata T, Naiki H, Hitomi S, Wada H. Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastases. Cancer 1999; 86: 1174-1181
12. Wu X, Zhang Z, Cai S. Proliferating cell nuclear antigen(PCNA) in ovarian carcinoma and its relation to lymph node metastasis and prognosis. Zhonghua Zhongliu Zazhi 1998; 20: 68-70
13. Luo YQ, Ma LS, Zhao YL, Wu KC, Pan BR, Zhang XY. Expression of proliferating cell nuclear antigen in polyps from large intestine. World J Gastroenterol 1999; 5: 160-164
14. Wu WY, Xu Q, Shi LC, Zhang WB. Inhibitory effects of Curcuma aromatica oil on proliferation of hepatoma in mice. World J Gastroenterol 2000; 6: 216-219
15. Lin GY, Chen ZL, Lu CM, Li Y, Ping XJ, Huang R. Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients. World J Gastroenterol 2000; 6: 234-238
16. Fan J, Wu ZQ, Tang ZY, Zhou J, Qiu SJ, Ma ZC, Zhou XD, Ye SL. Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein. World J Gastroenterol 2001; 7: 28-32
17. Rose DM, Chapman WC, Brockenbrough AT, Wright JK, Rose AT, Meranze S, Mazer M, Blair T, Blanke CD, Debelak JP, Pinson CW. Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. Am J Surg 1999; 177: 405-410
18. Xiao EH, Hu GD, Liu PC, Hu DY, Liu SC, Hao CY. The effect of different interventional treatment of P-glycoprotein in different histopathological types of primary hepatocellular carcinoma. Zhonghua Fangshexue Zazhi 1999; 33: 150-152
19. Okumura H, Natsugoe S, Nakashima S, Matsumoto M, Sakita H, Nakano S, Kusano C, Baba M, Takao S, Furukawa T, Akiyama SI, Aikou T. Apoptosis and cell proliferation in esophageal squamous cell carcinoma treated by chemotherapy. Cancer Lett 2000; 158: 211-216
20. Huang JF, He XS, Lin XJ. Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma. Chin Med J 2000; 113: 446-448
21. Sato S, Kigawa J, Minagawa Y, Okada M, Shimada M, Takahashi M, Kamazawa S, Terakawa N. Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma. Cancer 1999; 86: 1307-1313
22. Li JQ, Zhang CQ, Feng KT. PCNA, p53 protein and prognosis in primary liver cancer. China Natl J New Gastroenterol 1996; 2: 220-222
23. Kieser A, Weich HA, Brander G, Marme D, Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994; 9: 963-969
24. Igarashi N, Takahashi M, Ohkubo H, Omata K, Iida R, Fujimoto S. Predictive value of Ki-67, p53 protein, and DNA content in thr diagnosis of gastric carcinoma. Cancer 1999; 86: 1449-1454
25. Matsuura T, Fukuda Y, Fujitaka T, Nishisaka T, Sakatani T, Ito H. Preoperative treatment with Tegafur Suppositories enhances apoptosis and reduces the intratumoral microvessel density of human colorectal carcinoma. Cancer 2000; 88: 1007-1015
26. Deb S, Jackson CT, Subler MA, Martin DW. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells. J Virol 1992; 66: 6164-6170
27. Miyashita T, Krajewska S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799-1805
28. Ioachim E, Malamou-Mitsi V, Kamina SA, Goussia AC, Agnantis NJ. Immunohistochemical expression of Bcl-2 protein in breast lesions: Correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices. Anticancer Res 2000; 20: 4221-4226
29. Giatromanolaki A, Stathopoulos GP, Tsiobanou E, Papadimitriou C, Georgoulias V, Gatter KC, Harris AL, Koukourakis MI. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma. Cancer 1999; 86: 1421-1430
30. Zhao P, Yang GH, Mao X. A molecular pathological study of p53 gene in hepatocellular carcinoma. Zhonghua Binglixue Zazhi 1993; 22: 16-18
31. Xiao EH, Hu GD, Li JQ, Zhang YQ, Chen MS, Guo YP, Lin XG, Li SP, Shi M. The effect of transcatheter arterial chemoembolization on the different histopathological types of hepatocellular carcinoma. Zhonghua Gandanwaikexue Zazhi 2001; 7: 411-414
32. Wang YP, Zhang JS, Gao YA. Therapeutic efficacy of transcatheter arterial embolization of primary hepatocellular carcinoma: Discrepancy in different histopathological types of HCC. Zhonghua Fangshexue Zazhi 1997; 31: 586-591
33. Yamashita Y, Matsukawa T, Arakawa A, Hatanaka Y, Urata J, Takahashi M. US-guided liver biopsy: Predicting the effect of interventional treatment of hepatocellular carcinoma. Radiology 1995; 196: 799-804